Julie Tellier
- Immunology top 2%
- Immune Cell Function and Interaction 21
- T-cell and B-cell Immunology 15
- Immunotherapy and Immune Responses 9
- IL-33, ST2, and ILC Pathways 2
- Hematology top 5%
- Multiple Myeloma Research and Treatments 3
- Oncology top 10%
-
- Endoplasmic Reticulum Stress and Disease 3
-
- Cancer Mechanisms and Therapy 2
-
- Eosinophilic Esophagitis 2
- Co-authors
- Stephen L. NuttGabrielle T. BelzGordon K. SmythWei ShiAxel KalliesYang LiaoNicolas JacquelotCyril Seillet
- Cited by
- ImmunologyHematologyOncology
- Partner nations
- AustraliaFranceUnited States
In The Last Decade
Julie Tellier
28 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 90
- Immunology 1.1k
- Hematology 167
- Oncology 244
- Genetics 69
- Endocrine and Autonomic Systems 38
Countries citing papers authored by Julie Tellier
This map shows the geographic impact of Julie Tellier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julie Tellier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julie Tellier more than expected).
Fields of papers citing papers by Julie Tellier
This network shows the impact of papers produced by Julie Tellier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julie Tellier. The network helps show where Julie Tellier may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Julie Tellier, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 4 | |
| 2 | 2024 | 21 | |
| 3 | 2023 | 9 | |
| 4 | 2023 | 10 | |
| 5 | 2021 | 94 | |
| 6 | 2020 | 21 | |
| 7 | 2019 | 164 | |
| 8 | 2017 | 66 | |
| 9 | 2017 | 71 | |
| 10 | The transcriptional regulator, IRF4 is essential for the development of follicular T regulatory cells | 2016 | 1 |
| 11 | 2016 | 51 | |
| 12 | 2016 | 256 | |
| 13 | 2015 | 158 | |
| 14 | 2014 | 33 | |
| 15 | 2014 | 192 | |
| 16 | 2014 | 93 | |
| 17 | 2013 | 28 | |
| 18 | 2006 | 12 | |
| 19 | 2005 | 20 | |
| 20 | Valeur diagnostique du dosage radio-immunologique de la phosphatase acide prostatique. Intérêt comparé de la mesure de l'activité enzymatique. | 1981 | 2 |
About Julie Tellier
Julie Tellier is a scholar working on Immunology, Hematology and Oncology, having authored 28 papers that have together received 1.6k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (21 papers), T-cell and B-cell Immunology (15 papers), Immunotherapy and Immune Responses (9 papers), Multiple Myeloma Research and Treatments (3 papers), Endoplasmic Reticulum Stress and Disease (3 papers), Cancer Mechanisms and Therapy (2 papers), Eosinophilic Esophagitis (2 papers) and IL-33, ST2, and ILC Pathways (2 papers). The work is most often cited by research in Immunology (1.1k citations), Hematology (167 citations) and Oncology (244 citations). Julie Tellier has collaborated with scholars based in Australia, France and United States. Frequent co-authors include Stephen L. Nutt, Gabrielle T. Belz, Gordon K. Smyth, Wei Shi, Axel Kallies, Yang Liao, Nicolas Jacquelot, Cyril Seillet, Martina Minnich and Meinrad Busslinger.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.